Literature DB >> 25750296

MicroRNA-503 promotes tumor progression and acts as a novel biomarker for prognosis in oesophageal cancer.

Shozo Ide1, Yuji Toiyama2, Tadanobu Shimura1, Mikio Kawamura1, Hiromi Yasuda1, Susumu Saigusa1, Masaki Ohi1, Koji Tanaka1, Yasuhiko Mohri1, Masato Kusunoki1.   

Abstract

AIM: This study investigated microRNA (miR)-503 expression levels and evaluated its clinical significance in patients with oesophageal cancer (EC).
MATERIALS AND METHODS: miR-503 expression was quantified by quantitative reverse transcription-polymerase chain reaction in 49 EC tissue samples and 12 adjacent normal tissues from 49 patients with EC. The association between miR-503 expression and clinicopathological factors, including prognostic outcomes, were assessed.
RESULTS: miR-503 was found up-regulated in EC tissues compared to adjacent normal tissues. High miR-503 expression was significantly associated with large tumor size. Kaplan-Meier analysis showed that patients with high miR-503 expression had significantly poorer disease-free and overall survival than those with lower expression levels. High miR-503 expression was identified as an independent prognostic predictor in patients with EC according to multivariate analysis.
CONCLUSION: miR-503 expression affects tumor cell proliferation in EC. Evaluation of miR-503 expression might thus help identify patients with EC with poor prognosis and higher risk of early recurrence. Copyright
© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  biomarker; miR-503; oesophageal cancer; prognosis

Mesh:

Substances:

Year:  2015        PMID: 25750296

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  17 in total

1.  MicroRNA-503 serves an oncogenic role in retinoblastoma progression by directly targeting PTPN12.

Authors:  Yang Cheng; Wei Liu
Journal:  Exp Ther Med       Date:  2019-07-19       Impact factor: 2.447

Review 2.  The Role and Interactions of Programmed Cell Death 4 and its Regulation by microRNA in Transformed Cells of the Gastrointestinal Tract.

Authors:  William Frank Ferris
Journal:  Front Oncol       Date:  2022-06-29       Impact factor: 5.738

3.  miR-503 inhibits cell proliferation and invasion in glioma by targeting L1CAM.

Authors:  Hao Liu; Zhi Song; Daguang Liao; Tianyi Zhang; Feng Liu; Wen Zheng; Kui Luo; Liang Yang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

4.  MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma.

Authors:  Shanghui Guan; Cong Wang; Xuan Chen; Bowen Liu; Bingxu Tan; Fang Liu; Ding Wang; Lihui Han; Lu Wang; Xiaochen Huang; Jiangfeng Wang; Bin Yao; Jialei Shi; Pengxiang Chen; Effat Un Nesa; Qingxu Song; Yufeng Cheng
Journal:  Tumour Biol       Date:  2015-10-24

5.  MicroRNA-490-3p inhibits colorectal cancer metastasis by targeting TGFβR1.

Authors:  Xuehu Xu; Rong Chen; Zhifa Li; Nanqi Huang; Xiaobing Wu; Shuling Li; Yong Li; Shangbiao Wu
Journal:  BMC Cancer       Date:  2015-12-29       Impact factor: 4.430

6.  MicroRNA-503 suppresses cell proliferation and invasion in osteosarcoma via targeting insulin-like growth factor 1 receptor.

Authors:  Zili Wang; Chenhuang Zheng; Kunqi Jiang; Jinshen He; Xu Cao; Song Wu
Journal:  Exp Ther Med       Date:  2017-06-22       Impact factor: 2.447

7.  Similar Squamous Cell Carcinoma Epithelium microRNA Expression in Never Smokers and Ever Smokers.

Authors:  Antonia Kolokythas; Yalu Zhou; Joel L Schwartz; Guy R Adami
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

8.  Prognostic and diagnostic potential of miR-146a in oesophageal squamous cell carcinoma.

Authors:  Cong Wang; Shanghui Guan; Fang Liu; Xuan Chen; Lihui Han; Ding Wang; Effat Un Nesa; Xintong Wang; Cihang Bao; Nana Wang; Yufeng Cheng
Journal:  Br J Cancer       Date:  2016-01-21       Impact factor: 7.640

9.  Effect of miR-503 Down-Regulation on Growth and Invasion of Esophagus Carcinoma and Related Immune Function.

Authors:  Ke Zhao; Bao-Jun Chen; Zhi-Guo Chen; Yong-Jian Zhang; Di Xu; Qi Liu
Journal:  Med Sci Monit       Date:  2015-11-18

10.  MiR-503 inhibits hepatocellular carcinoma cell growth via inhibition of insulin-like growth factor 1 receptor.

Authors:  Yao Xiao; Qinggang Tian; Jiantai He; Ming Huang; Chao Yang; Liansheng Gong
Journal:  Onco Targets Ther       Date:  2016-06-15       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.